ADL 5859,
ADL-5859,
ADL5859,
N,N-diethyl-4-(5-hydroxyspiro(chromene-2,4'-piperidine)-4-yl)benzamide,
850173-95-4,
ADL5859 HCl,
ADL-5859,
ADL5859,
ADL5859 Hydrochloride,
ADL-5859 Hydrochloride,
N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide hydrochloride,
ADL 5859,
C24H29ClN2O3,
n,n-diethyl-4-(5-hydroxyspiro(2h-1-benzopyran-2,4'-piperidin)-4-yl)benzamide hydrochloride,
N,N-Diethyl-4-(5-hydroxyspiro[2h-1-benzopyran-2,4'-piperidin]-4-yl)benzamide hydrochloride,
N,N-diethyl-4-{5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl}benzamide hydrochloride,
Adl-5859 HCl,
cc-30,
MLS006010290,
DTXSID20677374,
EX-A433,
QCR-190,
AOB87750,
BCP01728,
ADL-5859/ADL5859,
ABP000192,
MFCD17215194,
s1139,
AKOS027327589,
API0010445,
CS-0428,
EX-8608,
RL05242,
4CA-0115,
AK326215,
AS-19401,
HY-13044,
SMR004701359,
DB-026462,
FT-0719997,
SW219439-1,
X7606,
A 5859,
W-5684,
J-523231,
ADL-5859;ADL5859;ADL 5859;850173-95-4,
N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidin]-4-yl)benzamide hydrochloride,
N,N-Diethyl-4-(5-hydroxyspiro[1-benzopyran-2,4'-piperidin]-4-yl)benzamide--hydrogen chloride (1/1),
D0W9ZT,
ZFNLSWREIULTDO-UHFFFAOYSA-N,
PF-04856880,
A10190,
A11072,
850173-95-4 (ADL 5859 HCl),
850305-06-5,